Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-05

FDA Approved: ANASTROZOLE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for Anastrozole from Zydus Lifesciences Limited. The document concerns the approval of a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)

Snippet

SUPPL AP for ANASTROZOLE (ANASTROZOLE)